SELENA PEVAHOUSE: Open Payments
NPI 1063052116 · CLIFTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 15 payments from 7 companies in 2025. Trend: 2023 $78 · 2024 $629 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $143 |
| Janssen Pharmaceuticals, Inc | 2 | $117 |
| ABBVIE INC. | 1 | $113 |
| Lundbeck LLC | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Alkermes, Inc. | 1 | $21 |
Products named: SPRAVATO, VRAYLAR, FANAPT, REXULTI, COBENFY, HETLIOZ, AUSTEDO XR, ARISTADA.
Industry payments across TN — which companies pay providers there.
